JD Health International Inc. reported that it repurchased 1.80 million ordinary shares on 27 May 2026 via on-market transactions, paying a total of HK$71.86 million at prices ranging from HK$39.18 to HK$40.58 per share. The shares are designated for cancellation.

Including this latest tranche, the company has bought back 13.42 million shares between 15 and 27 May 2026 under the repurchase mandate approved on 20 June 2025. The accumulated volume equals 0.419 % of JD Health’s issued share capital as at the mandate date.

JD Health is authorised to repurchase up to 320.01 million shares; the purchases completed to date represent 4.20 % of that limit, leaving substantial headroom for additional buybacks before the mandate expires.

Despite the recent activity, the company's issued share count remained unchanged at 3.21 billion ordinary shares as of 27 May 2026, as the repurchased shares had not yet been cancelled. A 30-day moratorium on new share issues, sales, or transfers of treasury shares is in effect until 26 June 2026, in accordance with Hong Kong Listing Rule 10.06(3)(a).